Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2016
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E O'Bryant, Michelle M Mielke, Robert A Rissman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study
Melissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome
Melissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Plos One
|
June 3, 2017
Investigating the effect of forestry on leaf-litter arthropods (Algonquin Park, Ontario, Canada)
M Alex Smith, Amanda Boyd, Amelia Chan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 11, 2026
The association between APOE 𝜀4 carrierships and the detection of amyloid positivity using an Alzheimer's disease proteomic blood test in asymptomatic Down syndrome
Lubnaa Badriyyah Abdullah, Fan Zhang, Melissa Petersen, et al.
Journal of Medicinal Chemistry
|
November 6, 2025
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2'-Deoxynucleoside 5'-Monophosphate Glycosidase (DNPH1)
Bernard Barlaam, Luz Alonso-Crisostomo, Niall A Anderson, et al.
Nature
|
February 24, 2022
Effective drug combinations in breast, colon and pancreatic cancer cells
Patricia Jaaks, Elizabeth A Coker, Daniel J Vis, et al.
Molecular Systems Biology
|
July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens
Emanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Journal of Medicinal Chemistry
|
November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACs
Niall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Nature Communications
|
October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2016
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E O'Bryant, Michelle M Mielke, Robert A Rissman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study
Melissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome
Melissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Plos One
|
June 3, 2017
Investigating the effect of forestry on leaf-litter arthropods (Algonquin Park, Ontario, Canada)
M Alex Smith, Amanda Boyd, Amelia Chan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 11, 2026
The association between APOE 𝜀4 carrierships and the detection of amyloid positivity using an Alzheimer's disease proteomic blood test in asymptomatic Down syndrome
Lubnaa Badriyyah Abdullah, Fan Zhang, Melissa Petersen, et al.
Journal of Medicinal Chemistry
|
November 6, 2025
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2'-Deoxynucleoside 5'-Monophosphate Glycosidase (DNPH1)
Bernard Barlaam, Luz Alonso-Crisostomo, Niall A Anderson, et al.
Nature
|
February 24, 2022
Effective drug combinations in breast, colon and pancreatic cancer cells
Patricia Jaaks, Elizabeth A Coker, Daniel J Vis, et al.
Molecular Systems Biology
|
July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens
Emanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Journal of Medicinal Chemistry
|
November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACs
Niall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Nature Communications
|
October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.
Page
of 18